Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Wednesday's After-Market Session

Author: Benzinga Insights | December 06, 2023 05:31pm

Gainers

  • Reshape Lifesciences (NASDAQ:RSLS) stock moved upwards by 17.9% to $0.31 during Wednesday's after-market session. The market value of their outstanding shares is at $4.0 million.
  • Monopar Therapeutics (NASDAQ:MNPR) shares moved upwards by 15.5% to $0.4. The company's market cap stands at $5.9 million.
  • Cerevel Therapeutics Hldg (NASDAQ:CERE) stock rose 13.99% to $42.1. The market value of their outstanding shares is at $7.5 billion.
  • Altamira Therapeutics (NASDAQ:CYTO) shares moved upwards by 13.37% to $0.63. The market value of their outstanding shares is at $5.0 million.
  • Sera Prognostics (NASDAQ:SERA) stock increased by 7.81% to $5.93. The market value of their outstanding shares is at $185.8 million.
  • Bionomics (NASDAQ:BNOX) stock rose 7.25% to $1.33. The company's market cap stands at $10.8 million.

Losers

  • WAVE Life Sciences (NASDAQ:WVE) stock declined by 18.4% to $5.6 during Wednesday's after-market session. The market value of their outstanding shares is at $554.7 million.
  • MaxCyte (NASDAQ:MXCT) stock declined by 11.12% to $4.56. The market value of their outstanding shares is at $472.3 million.
  • Rani Therapeutics Hldgs (NASDAQ:RANI) stock decreased by 7.34% to $2.4. The market value of their outstanding shares is at $62.1 million.
  • Eterna Therapeutics (NASDAQ:ERNA) shares declined by 6.67% to $1.4. The market value of their outstanding shares is at $7.5 million.
  • Applied DNA Sciences (NASDAQ:APDN) shares fell 6.31% to $1.04. The market value of their outstanding shares is at $14.2 million.
  • OptiNose (NASDAQ:OPTN) shares declined by 5.7% to $1.16. The company's market cap stands at $130.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: APDN BNOX CERE CYTO ERNA MNPR MXCT OPTN RANI RSLS SERA WVE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist